Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The findings provide support for phase 2 development of LY3437943 for the treatment of type 2 diabetes and obesity since the medication can produce robust reductions in body weight and blood sugar levels
Retatrutide is an investigational triple receptor agonist being studied for its effects on appetite control, metabolism and energy balance
W., Chang, W
M., et al., International Journal of Obesity , Vol
US$ 21.87
US$ 25.37
US$ 24.14
US$ 25.00
US$ 26.61
US$ 21.18
US$ 29.78
US$ 22.06
US$ 29.38
US$ 22.80
US$ 28.89
